How many insider trades does FilingIQ track for YDES?

FilingIQ tracks 7 Form 4 insider transactions for YDES (YD Bio Ltd), covering filings from Apr 2, 2026 onwards. 3 of those are dated within the last 90 days.

Are YDES insiders net buyers or net sellers?

Across the full Form 4 history for YDES, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does YDES insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is YDES in?

YD Bio Ltd (YDES) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $523.97M.

YDES insider trading

NasdaqGM Healthcare

YD Bio Ltd: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

43% / 0%

Market cap

$523.97M

About YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Company website: www.ydesgroup.com

YDES insider activity at a glance

FilingIQ tracks 7 insider transactions for YDES in filings since Apr 2, 2026. The most recent transaction is dated Sep 14, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on YDES insider trades is 60.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live YDES trades on FilingIQ Raw filings on SEC EDGAR

Latest YDES Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for YDES?: FilingIQ tracks 7 Form 4 insider transactions for YDES (YD Bio Ltd), covering filings from Apr 2, 2026 onwards. 3 of those are dated within the last 90 days.
Are YDES insiders net buyers or net sellers?: Across the full Form 4 history for YDES, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does YDES insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is YDES in?: YD Bio Ltd (YDES) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $523.97M.

Methodology & sources

Every YDES insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.